• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Bicyclic monoterpenoids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Monoterpenoids Bicyclic monoterpenoids

Introduction to 7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic Acid (CAS No. 40724-67-2)

7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic Acid, identified by its Chemical Abstracts Service (CAS) number 40724-67-2, is a structurally unique organic compound that has garnered significant attention in the field of medicinal chemistry and chemical biology due to its distinct bicyclic framework and functional properties. This compound belongs to the class of oxobicycloalkanes, which are characterized by their rigid three-membered oxygen-containing ring fused to a larger cycloalkane system. The presence of two methyl groups at the 7-position and a carboxylic acid functionality at the 1-position introduces specific steric and electronic characteristics that make this molecule a promising candidate for various applications in synthetic chemistry and drug discovery.

The bicyclo[2.2.1]heptane scaffold is particularly interesting because it mimics the structural motifs found in several natural products and bioactive molecules. The oxo group (C=O) at the 2-position introduces polarity and potential hydrogen bonding capabilities, while the carboxylic acid moiety provides a site for further derivatization, such as esterification or amidation, which can modulate the compound's solubility, bioavailability, and pharmacological activity. These features have made 7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic Acid a subject of interest in the design of novel therapeutic agents.

In recent years, there has been growing interest in the development of bicyclic compounds as pharmacophores due to their ability to fit into biological targets with high specificity and affinity. The rigid structure of bicyclo[2.2.1]heptane derivatives often enhances binding interactions within macromolecular targets such as enzymes and receptors. Furthermore, the incorporation of functional groups like carboxylic acids allows for fine-tuning of physicochemical properties, making these compounds valuable intermediates in medicinal chemistry.

One of the most compelling aspects of 7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic Acid is its potential as a building block for more complex molecules. Its unique cyclic structure and functional handles provide chemists with a versatile platform for generating novel scaffolds through combinatorial chemistry or directed evolution approaches. This has led to several studies exploring its utility in generating libraries of diverse compounds for high-throughput screening (HTS) in drug discovery programs.

Recent advancements in computational chemistry have also highlighted the importance of bicyclic structures in drug design. Molecular modeling studies have demonstrated that compounds featuring the bicyclo[2.2.1]heptane core can exhibit favorable interactions with biological targets due to their preorganized conformation and rigid geometry. These features are particularly relevant in the context of enzyme inhibition, where precise spatial orientation of substituents is critical for effective binding.

The carboxylic acid group in 7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic Acid offers additional opportunities for chemical manipulation. For instance, it can be converted into esters or amides, which are common pharmacophoric elements in many approved drugs. These derivatives can exhibit enhanced metabolic stability or altered pharmacokinetic profiles compared to their parent compound, making them attractive candidates for further development.

Moreover, the dimethyl substitution at the 7-position contributes to the steric environment around the bicyclic core, influencing both electronic properties and molecular recognition events. This feature has been exploited in several synthetic strategies aimed at generating conformationally constrained analogs with improved binding affinities or selectivity.

In conclusion, 7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic Acid (CAS No. 40724-67-2) represents a structurally fascinating compound with significant potential in medicinal chemistry and chemical biology. Its unique bicyclic framework combined with functional handles like the carboxylic acid group makes it a versatile scaffold for drug discovery efforts aimed at developing novel therapeutic agents.

• 6994-94-1(Bicyclo[2.2.1]heptane-1-carboxylicacid, 7,7-dimethyl-2-oxo-)
• 88564-20-9(Spiro[4.5]decane-6-carboxylic acid, 6-butyl-1,7-dioxo-, cis-)
• 760175-74-4(Bicyclo[3.1.0]hexane-2-carboxylicacid, 2-methyl-5-(1-methylethyl)-3-oxo-, (1S,2S,5S)-)
• 61259-07-2(Cyclopentanecarboxylic acid, 1-(cyclohexylcarbonyl)-)
• 474-98-6((+/-)-3-Camphorcarboxylic Acid)
• 18530-30-8(Bicyclo[2.2.1]heptane-2-carboxylicacid, 4,7,7-trimethyl-3-oxo-, (1R,2S,4R)-)
• 18530-29-5((-)-camphorcarboxylic acid)
• 64234-14-6((1R)-(-)-Ketopinicacid)
• 464-78-8(7,7-dimethyl-2-oxo-norbornane-1-carboxylic acid)
• 19495-28-4(Bismuth,tris(4,7,7-trimethyl-3-oxobicyclo[2.2.1]heptane-2-carboxylato-O2,O3)- (9CI))